top of page
What Makes Our Models Unique
XenoSTART patient-derived xenograft (XPDX) models are established from patients treated at The START Center, a global oncology treatment and research organization. Models from chemo-naïve and pretreated patients in over twenty-five indications are available for in vivo evaluation or licensing.
Request Form
Request Access To Our Catalog
bottom of page